Skip to main content
Clinical Trials/NCT05999695
NCT05999695
Enrolling By Invitation
Not Applicable

Effects of the Self-management on Anxiety, Depression, Quality of Life and Self-management of Patients With Acute Coronary Syndromes: a Randomized Controlled Trial.

Taipei Veterans General Hospital, Taiwan1 site in 1 country104 target enrollmentDecember 11, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Coronary Syndromes
Sponsor
Taipei Veterans General Hospital, Taiwan
Enrollment
104
Locations
1
Primary Endpoint
Hospital Anxiety and Depression Scale, HADS
Status
Enrolling By Invitation
Last Updated
2 years ago

Overview

Brief Summary

Purpose :

The purpose of this study is to investigate the tracking effect of selfmanagement programs on anxiety, depression, and quality of life in patients with Acute Coronary Syndromes (ACS).

Detailed Description

Research Design : This study the first phase is to construct and develop interventional measures for self-management of patients with ACS. According to the associated factors of study, the intervention measures are designed based on self-management. A pilot study will be conducted to improve research and to develop better selfmanagement interventions in the future. At the secondary stage: a randomized controlled trial with a random sampling design is used to investigate the effects of self-management programs on anxiety, depression, and quality of life in patients with ACS. The study will conduct in a cardiac medicine ward or coronary intensive care center of a north medical center. Patients with ACS,who met the conditions and agreed to join the study will be recruited. Then,the informed consent will be obtained. At the first stage, 10subjects will be collect. At the secondary stage, a total of 104 subjects will be enrolled, 52 in the experimental group will receive the self-management program, and 52 in the control group will receive a routine hospital care. Method \& Results: The data of demographic and disease characteristics, clinical indicators,depression, anxiety, self-management, and quality of life will be collected.The Hospital Anxiety and Depression Scale, the SF-36 Taiwan version of the Quality-of-Life Questionnaire and the Self-Management Scale will used as tools to collect data. The efficacy of the intervention will be collected 1 month and 3 months after the intervention. Data will be statistically analyzed by GEE. Hypothesis : It is expected that the self-management program applied to patients with ACS can reduce depression and anxiety, thereby improving the quality of life.

Registry
clinicaltrials.gov
Start Date
December 11, 2022
End Date
August 26, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cheng, Hui- Chuan

Nursing Supervisor

Taipei Veterans General Hospital, Taiwan

Eligibility Criteria

Inclusion Criteria

  • Over 20 years old
  • The first diagnosis of acute coronary syndrome by a clinician,
  • Clear consciousness, able to converse in Chinese and Taiwanese languages.
  • Willingness to participate in this research

Exclusion Criteria

  • Those who are unable to take care of themselves
  • Poor vision and inability to read
  • Hard of hearing and deafness
  • Inability to communicate

Outcomes

Primary Outcomes

Hospital Anxiety and Depression Scale, HADS

Time Frame: First time(baseline) is in the first day in the ward.The second time is one month after discharge.The third time is three months after discharge.

The Likert four-point scale (0-3 points) was used, and the two items were scored separately, and the total score was between 0-21 points. The higher the score, the higher the degree of anxiety or depression. A score below 7 means no anxiety or depression, a score between 8 and 10 means the patient is suspected of anxiety or depression, and a score greater than or equal to 11 means that the patient has anxiety or depression. It is a measure to assess change at three-time points. change from Baseline Anxiety and Depression at 1 and 3 months.

The Partner In Health scale, PIH

Time Frame: First time(baseline) is in the first day in the ward.The second time is one month after discharge.The third time is three months after discharge

Items in the scale are graded on a nine-point scale, with 0 representing the worst and 8 representing the best. This is a closed and continuous variable. The scale scores range from 0 to 96, with higher scores indicating better selfmanagement. It is a measure to assess change at three-time points. Change from self-management Baseline at 1 and 3 months.

The MOS 36-Item Short-Form Health Survey,SF36

Time Frame: First time(baseline) is in the first day in the ward.The second time is one month after discharge.The third time is three months after discharge

Scores range from 0 to 100, with higher scores indicating better self-assessed health. Each item of the questionnaire is calculated separately according to the designed initial scores. Then the scores of the items related to each scale are added up and then subtracted from each scale to obtain the lowest score. Divide by the distance between the possible scores of each scale, and multiply by 100 to get the score. It is a measure to assess change at three-time points. change from Baseline quality of life at 1 and 3 months.

Study Sites (1)

Loading locations...

Similar Trials